Skip to main content
Download PDF

The coagulation status in women of endometriosis with stage IV

BMC Women's Health volume 24, Article number: 386 (2024) Cite this article

Abstract

Background

Endometriosis is considered as a systemic disease with the presence of proinflammatory cytokines in the circulation, which drives hypercoagulable state of endometriosis. Currently, endometriosis is classified into four stages: I (minimal), II (mild), III (moderate) and IV (severe). The aim of this study is to investigate the correlations between inflammatory markers and coagulation factors in patients diagnosed of endometriosis with stage IV.

Methods

This retrospective case–control study included 171 endometriosis patients with stage IV and 184 controls. Continuous data were expressed by mean ± standard deviation. Mann–Whitney U and χ2 tests were used to compare the medians and frequencies among the groups. Spearman analysis was conducted to determine the correlation among the measured parameters. The diagnostic values of the parameters differentiating endometriomas were tested by receiver operating characteristic (ROC) curve.

Results

The time of activated partial thromboplastin time (APTT) was decreased and the concentration of fibrinogen (FIB) and neutrophil-to-lymphocyte ratio (NLR) were increased in women of endometriosis with stage IV. The APTT were negatively correlated with NLR while the concentrations of FIB were positively correlated with NLR. The ROC analysis showed that the Area under the curve (AUC) of FIB was 0.766 (95% confidence interval:0.717–0.814) with sensitivity and specificity reaching 86.5 and 60.9%, respectively. The AUC of CA125 and CA199 was 0.638 (95% confidence interval: 0.578–0.697), 0.71 (95% confidence interval: 0.656–0.763) with sensitivity and specificity reaching 40.9 and 91.8%, 80.7 and 56.5% respectively. The combination of these factors showed the highest AUC of 0.895 (0.862–0.927) with sensitivity of 88.9% and specificity of 77.7%.

Conclusion

In the present study, we found that inflammatory factors showed significant correlation with APTT or FIB in endometriosis with stage IV. Moreover, the coagulation factors combined with CA125 and CA199 were more reliable for identifying the endometriosis with stage IV.

Peer Review reports

Introduction

Endometriosis is a chronic disease characterized by the presence of endometrial-like tissue outside the uterus [1]. This disorder is estimated to affect 5–10% of women of reproductive age [2]. Endometriosis is observed in 40–50% of women with persistent pelvic pain and up to 50% of women with infertility [3]. The diagnosis of endometriosis is typically delayed by years although it is prevalent. The laparoscopy is considered as the gold standard of diagnosis for endometriosis. Heretofore, there is no reliable blood diagnostic biomarkers for endometriosis [4].

Currently, endometriosis is usually treated by surgery therapy. Endometriosis is recognized classified into four stages: I (minimal), II (mild), III (moderate) and IV (severe) [5]. Women of endometriosis with stage IV showed extensive lesions and more pelvic adhesions, which making surgery therapy more difficult [6]. It is necessary for us to identify the patients of endometriosis with stage IV before surgery, which could help us adequately prepare for surgery.

Endometriosis is a systemic inflammatory condition with the presence of proinflammatory cytokines in the circulation [7, 8]. In patients with endometriosis, the inflammation leads to the endometriosis-associated pain, endothelial dysfunction and carcinogenesis even though [7, 9]. The activation of inflammation also drives hypercoagulable state [10, 11]. The decreased levels of thrombin time (TT), activated partial thromboplastin time (APTT) and increased level of tissue factor (TF), fibrinogen have been found in patients with endometriosis [12,13,14,15]. However, the correlation between inflammatory markers and coagulation factors of endometriosis with stage IV has not been clearly clarified.

In the present study, we aimed to investigate the correlations between inflammatory markers and coagulation factors in patients diagnosed of endometriosis with stage IV. We also explored the diagnostic value of these parameters in endometriosis with stage IV, which provide new ideas for diagnosis with auxiliary biomarkers.

Methods

Patients

This research was approved by the ethics committee of the Nanjing Drum Tower Hospital (2024-094-01) in accordance with the Declaration of Helsiniki. A total of 355 patients including 171 endometriosis patients with stage IV and 184 controls who underwent surgery between January 2022 and December 2023 was participated. The stage of endometriosis was established according to the revised classification of the American Society for Reproductive Medicine [5]. The control group included patients with a surgical diagnosis of uterine leiomyomas, tubal pathology and ovarian benign cysts. All patients included in this research owned a histopathological diagnosis after either laparoscopic or laparotomic surgery. The patients in control group showed no stage of endometriosis by both the surgical and the histopathological examinations. All women have provided their informed consent for their clinical data to be used for researches purposes. The inclusion criteria were as follows: nonpregnant reproductive-age women and a surgical indication for endometriosis or other pelvic diseases. The exclusion criteria were as follows: patients in pregnancy or menopause; patients complicated autoimmune, hematological or blood coagulation diseases; patients with abnormal hepatic and renal function tests; patients who had taken corticosteroids and contraceptives within 3 months before surgery; patients with a diagnosis of malignancy.

Blood assay

Before surgery, all patients had routine blood analyses including complete blood count parameters, serum biochemistry, activated partial thromboplastin time (APTT), thrombin time (TT), prothrombin time (PT), fibrinogen (FIB), neutrophil-to-lymphocyte ratio (NLR), serum carbohydrate antigen (CA) 125 and CA199. The NLR was obtained from dividing the absolute neutrophil count by the absolute lymphocyte count. All blood analyses were established during either the follicular or the luteal phase before surgery.

Statistical analysis

The data was analyzed by SPSS 22.0 software (Chicago SPSS Co., Ltd.). Continuous data were expressed by mean ± standard deviation. Mann–Whitney U and χ2 tests were used to compare the medians and frequencies among the groups. Spearman analysis was conducted to determine the correlation among the measured parameters. The diagnostic values of the parameters differentiating endometriomas were tested by receiver operating characteristic (ROC) curve. P < 0.05 is considered as statistical difference.

Results

Patients’ characteristics

It was found that there were no statistical differences in age, BMI between Endometriosis with stage IV and Control groups (P > 0.05). Compared with the Control group, the parity was significantly lower, and the incidence of dysmenorrhea was significantly higher in the Endometriosis group (P < 0.05). No statistical difference was observed in the size of ovarian cysts between the Endometriosis and Control groups (P > 0.05, Table 1).

Table 1 Baseline characteristics of controls and patients of endometriosis with stage IV.
Full size table

The comparisons of inflammatory and coagulation markers between control and endometriosis with stage IV

To explore the coagulation state in women of endometriosis with stage IV, we compared the APTT, TT, PT and FIB between two groups. As shown in Fig. 1a, the time of APTT was significantly decreased in women of endometriosis with stage IV. The concentration of FIB was apparently increased in women of endometriosis with stage IV (Fig. 1d). However, the time of TT and PT showed no difference between two groups (Fig. 1b-c). These results showed that the women of endometriosis with stage IV exhibited a high coagulation state. Meanwhile, we also compared the inflammatory state between two groups. The level of NLR increased in women of endometriosis with stage IV, which showed no significant difference between proliferative and secretory phase ((Fig. 1e and Supplementary Fig. 1). Besides, we investigated the correlation between coagulation factors and NLR. The correlation analysis showed that the APTT were negatively correlated with NLR while the concentrations of FIB were positively correlated with NLR (Fig. 2a-d). These results showed that the coagulation factors are closely related to inflammation.

Fig. 1
figure 1

The coagulation factors and NLR in groups. a-d, Coagulation factors of APTT(a), TT(b), PT(c) and FIB(d) between controls and endometriosis with stage IV. e, NLR between controls and endometriosis with stage IV. APTT, activated partial thromboplastin time; TT, thrombin time; PT, prothrombin time; FIB, fibrinogen; NLR, neutrophil-to-lymphocyte ratio. ** P < 0.01, **** P < 0.0001

Full size image
Fig. 2
figure 2

Correlations of coagulation factors and NLR in women of endometriosis with stage IV. a-d, The correlations of NLR with APTT (a), TT (b), PT (c) and FIB (d) were tested using Spearmen analysis. APTT, activated partial thromboplastin time; TT, thrombin time; PT, prothrombin time; FIB, fibrinogen; NLR, neutrophil-to-lymphocyte ratio

Full size image

The diagnostic value of coagulation factors, CA125 and CA199 in endometriosis with stage IV

We investigated the diagnostic effects of coagulation factors, CA125 and CA199 by ROC analysis. As shown in Table 2; Fig. 3a, among coagulation factors, FIB exhibited maximum Area under the curve (AUC) which was 0.766 (95% confidence interval:0.717–0.814) with sensitivity and specificity reaching 86.5% and 60.9%, respectively. The AUC of CA125 was 0.638 (95% confidence interval: 0.578–0.697) with sensitivity and specificity reaching 40.9% and 91.8%, respectively. Besides, the AUC of CA199 was 0.71 (95% confidence interval: 0.656–0.763) with sensitivity and specificity reaching 80.7% and 56.5%, respectively. However, the combination of these factors showed the highest AUC of 0.895 (0.862–0.927) with sensitivity of 88.9% and specificity of 77.7% (Table 2; Fig. 3b).

Table 2 The diagnostic value of coagulation factors, CA125, CA199 and combined factor in patients of endometriosis with stage IV.
Full size table
Fig. 3
figure 3

Receiver operating characteristic curves of CA125, CA199, coagulation factors and the combined marker for the diagnosis of endometriomas with stage IV. a, The ROC analysis of CA125, CA199 and coagulation factors for the diagnosis of endometriomas with stage IV. b, The ROC analysis of combined marker for the diagnosis of endometriomas with stage IV. ROC, receiver operating characteristic; APTT, activated partial thromboplastin time; TT, thrombin time; PT, prothrombin time; FIB, fibrinogen; NLR, neutrophil-to-lymphocyte ratio

Full size image

Discussion

In summary, we confirmed that the coagulation factors were changed in women of endometriosis with stage IV in this study. APTT and FIB showed significantly correlation with NLR. Moreover, the combination of coagulation factors with CA125 and CA199 showed useful diagnostic value for endometriosis with stage IV. However, we still have some limitations. Firstly, this research was a retrospective study. Secondly, the patients in controls were surgical population.

Endometriosis is a chronic and systemic disease which could cause persistent pelvic and infertility [16]. The symptoms involve deep dyspareunia, severe dysmenorrhea, as well as bladder and bowel fatigue [17]. This disorder is so complex and heretofore, there is no effective treatment. To some extent, hormonal and surgical treatments have limitations and they could not address the systemic syndrome. In addition, endometriosis is related to mental health, social life, affecting work productivity, which leads to a major economic burden [18,19,20,21]. Unfortunately, besides pathological diagnosis after laparoscopic examination, there is no other effective non-invasive diagnostic method.

Inflammation is an important response in the pathogenesis of endometriosis. Inflammation could lead to dysfunction of endothelial, even promotes carcinogenesis [7]. Many inflammatory factors, such as tumor necrosis factor (TNF)-alpha, interleukin (IL)-1beta, IL-33 and IL-6, were upregulated in peritoneal fluid of women with endometriosis [22, 23]. Besides, inflammatory cells, including neutrophils and macrophages, were activated in endometrium of women with endometriosis [24]. Moreover, increased evidences indicated that there existed a cross-talk between inflammation and coagulation, whereby the initiation of inflammation could lead to the activation of coagulation [12]. In the present study, we found that inflammatory factors showed significant correlation with APTT or FIB in endometriosis with stage IV.

The combination of CA125 and CA199 showed diagnostic value of the endometriosis [25, 26]. Nevertheless, the predictive value of individual markers was limited. Some studies reported that CA125 combined with NLR showed useful diagnostic values, but the combination was not suitable for advanced endometriosis [27,28,29]. In our study, we found that coagulation factors combined with CA125 and CA199 were more reliable for identifying the endometriosis with stage IV.

In conclusion, inflammation and coagulation factors are crucial in the pathogenesis of endometriosis. Further studies on coagulation parameters or inflammatory markers combined with tumor markers would help to identify a new therapeutic strategy.

Data availability

Data is provided within the manuscript or supplementary information files.

References

  1. Horne AW, Saunders PTK. SnapShot: endometriosis. Cell. 2019;179(7):1677–1677. e1671.

    Article  CAS  PubMed  Google Scholar 

  2. Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet. 2021;397(10276):839–52.

    Article  CAS  PubMed  Google Scholar 

  3. Allaire C, Bedaiwy MA, Yong PJ. Diagnosis and management of endometriosis. CMAJ. 2023;195(10):E363–71.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Horne AW, Missmer SA. Pathophysiology, diagnosis, and management of endometriosis. BMJ. 2022;379:e070750.

    Article  PubMed  Google Scholar 

  5. Revised American Society for Reproductive Medicine classification of endometriosis. 1996. Fertil Steril. 1997;67(5):817–21.

  6. Zhao H, Zhang J, Bao ZL, Kong J, Wei W, Gu JQ. A preoperative predictive model for stage IV endometriosis. J Obstet Gynaecol. 2023;43(1):2188072.

    Article  PubMed  Google Scholar 

  7. Jiang L, Yan Y, Liu Z, Wang Y. Inflammation and endometriosis. Front Biosci (Landmark Ed). 2016;21(5):941–8.

    Article  CAS  PubMed  Google Scholar 

  8. Vallee A, Lecarpentier Y. Curcumin and Endometriosis. Int J Mol Sci 2020, 21(7).

  9. Wei Y, Liang Y, Lin H, Dai Y, Yao S. Autonomic nervous system and inflammation interaction in endometriosis-associated pain. J Neuroinflammation. 2020;17(1):80.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Choi G, Schultz MJ, Levi M, van der Poll T. The relationship between inflammation and the coagulation system. Swiss Med Wkly. 2006;136(9–10):139–44.

    PubMed  Google Scholar 

  11. Witkowski M, Landmesser U, Rauch U. Tissue factor as a link between inflammation and coagulation. Trends Cardiovasc Med. 2016;26(4):297–303.

    Article  CAS  PubMed  Google Scholar 

  12. Vigano P, Ottolina J, Sarais V, Rebonato G, Somigliana E, Candiani M. Coagulation Status in Women with endometriosis. Reprod Sci. 2018;25(4):559–65.

    Article  PubMed  Google Scholar 

  13. Ding S, Lin Q, Zhu T, Li T, Zhu L, Wang J, Zhang X. Is there a correlation between inflammatory markers and coagulation parameters in women with advanced ovarian endometriosis? BMC Womens Health. 2019;19(1):169.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Ling X, Wang T. Diagnostic and prognostic value of coagulation-related factors in endometriosis. Am J Transl Res. 2022;14(11):7924–31.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Li Y, Liu H, Ye S, Zhang B, Li X, Yuan J, Du Y, Wang J, Yang Y. The effects of coagulation factors on the risk of endometriosis: a mendelian randomization study. BMC Med. 2023;21(1):195.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Shim JY, Laufer MR. Adolescent endometriosis: an update. J Pediatr Adolesc Gynecol. 2020;33(2):112–9.

    Article  PubMed  Google Scholar 

  17. Saunders PTK, Horne AW. Endometriosis: etiology, pathobiology, and therapeutic prospects. Cell. 2021;184(11):2807–24.

    Article  CAS  PubMed  Google Scholar 

  18. Chen LC, Hsu JW, Huang KL, Bai YM, Su TP, Li CT, Yang AC, Chang WH, Chen TJ, Tsai SJ, et al. Risk of developing major depression and anxiety disorders among women with endometriosis: a longitudinal follow-up study. J Affect Disord. 2016;190:282–5.

    Article  PubMed  Google Scholar 

  19. Soliman AM, Yang H, Du EX, Kelley C, Winkel C. The direct and indirect costs associated with endometriosis: a systematic literature review. Hum Reprod. 2016;31(4):712–22.

    Article  PubMed  Google Scholar 

  20. Soliman AM, Coyne KS, Gries KS, Castelli-Haley J, Snabes MC, Surrey ES. The effect of endometriosis symptoms on Absenteeism and Presenteeism in the Workplace and at Home. J Manag Care Spec Pharm. 2017;23(7):745–54.

    PubMed  Google Scholar 

  21. Della Corte L, Di Filippo C, Gabrielli O, Reppuccia S, La Rosa VL, Ragusa R et al. The burden of endometriosis on women’s lifespan: a narrative overview on quality of life and psychosocial wellbeing. Int J Environ Res Public Health. 2020;17(13).

  22. Cheong YC, Shelton JB, Laird SM, Richmond M, Kudesia G, Li TC, Ledger WL. IL-1, IL-6 and TNF-alpha concentrations in the peritoneal fluid of women with pelvic adhesions. Hum Reprod. 2002;17(1):69–75.

    Article  CAS  PubMed  Google Scholar 

  23. Kato T, Yasuda K, Matsushita K, Ishii KJ, Hirota S, Yoshimoto T, Shibahara H. Interleukin-1/-33 signaling pathways as therapeutic targets for endometriosis. Front Immunol. 2019;10:2021.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Leiva MC, Hasty LA, Lyttle CR. Inflammatory changes of the endometrium in patients with minimal-to-moderate endometriosis. Fertil Steril. 1994;62(5):967–72.

    Article  CAS  PubMed  Google Scholar 

  25. Rokhgireh S, Mehdizadeh Kashi A, Chaichian S, Delbandi AA, Allahqoli L, Ahmadi-Pishkuhi M, Khodaverdi S, Alkatout I. The diagnostic accuracy of combined enolase/Cr, CA125, and CA19-9 in the detection of endometriosis. Biomed Res Int. 2020;2020:5208279.

  26. Chen T, Wei JL, Leng T, Gao F, Hou SY. The diagnostic value of the combination of hemoglobin, CA199, CA125, and HE4 in endometriosis. J Clin Lab Anal. 2021;35(9):e23947.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Yavuzcan A, Caglar M, Ustun Y, Dilbaz S, Ozdemir I, Yildiz E, Ozkara A, Kumru S. Evaluation of mean platelet volume, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in advanced stage endometriosis with endometrioma. J Turk Ger Gynecol Assoc. 2013;14(4):210–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Kim SK, Park JY, Jee BC, Suh CS, Kim SH. Association of the neutrophil-to-lymphocyte ratio and CA 125 with the endometriosis score. Clin Exp Reprod Med. 2014;41(4):151–7.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Tokmak A, Yildirim G, Oztas E, Akar S, Erkenekli K, Gulsen P, Yilmaz N, Ugur M. Use of Neutrophil-to-lymphocyte ratio combined with CA-125 to Distinguish Endometriomas from other Benign Ovarian cysts. Reprod Sci. 2016;23(6):795–802.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

None.

Funding

No specific funding was obtained.

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, China

    Lu Wang, Jingxian Ling, Xianghong Zhu, Yan Zhang, Rong Li, Jingjing Huang, Doudou Huang, Chan Wu & Huaijun Zhou

Authors
  1. Lu Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jingxian Ling
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xianghong Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rong Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jingjing Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Doudou Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Chan Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Huaijun Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

LW, CW and HJZ performed the research and revised the paper. JXL, XHZ, YZ, RL, JJH and DDH performed the data extraction and data analysis. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Chan Wu or Huaijun Zhou.

Ethics declarations

Ethics approval and consent to participate

This study is approved by the Human Ethics Committee of the Nanjing Drum Tower Hospital (2024-094-01) and all women provided written informed consent.

Competing interests

The authors declare no competing interests.

Consent for publication

Not applicable.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, L., Ling, J., Zhu, X. et al. The coagulation status in women of endometriosis with stage IV. BMC Women's Health 24, 386 (2024). https://doi.org/10.1186/s12905-024-03227-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12905-024-03227-4

Keywords

BMC Women's Health

ISSN: 1472-6874

Contact us